Medical Cannabis and Conditions Affecting Assigned Female At Birth and Intersex People (for Pharmacists)
-
Overview
Designed for pharmacists, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go underrecognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks.
With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of:
- Endometriosis
- Dysmenorrhoea
- Polycystic Ovary Syndrome (PCOS)
- Premenstrual Dysphoric Disorder (PMDD)
- Postpartum Depression (PPD)
- Breast, ovarian, and uterine cancers
- Perimenopause and menopause
Additionally, it covers critical pregnancy-related contraindications for medical cannabis.
Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes.
This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients.
Preview this course by watching the video above.
Estimated Duration: 4 hours
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this course, you’ll be able to:
- Assess when and how medical cannabis may improve treatment outcomes for IAFABP
- Make informed recommendations to patients and their doctors around medical cannabis as a treatment option
- Deliver exceptional patient-centred care by understanding your patients' experiences and exploring their options, you will be equipped to offer compassionate, professional and attentive care when your patients ask questions or come to dispense their medications
Overview
Designed for pharmacists, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go underrecognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks.
With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of:
- Endometriosis
- Dysmenorrhoea
- Polycystic Ovary Syndrome (PCOS)
- Premenstrual Dysphoric Disorder (PMDD)
- Postpartum Depression (PPD)
- Breast, ovarian, and uterine cancers
- Perimenopause and menopause
Additionally, it covers critical pregnancy-related contraindications for medical cannabis.
Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes.
This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients.
Preview this course by watching the video above.
Estimated Duration: 4 hours
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this course, you’ll be able to:
- Assess when and how medical cannabis may improve treatment outcomes for IAFABP
- Make informed recommendations to patients and their doctors around medical cannabis as a treatment option
- Deliver exceptional patient-centred care by understanding your patients' experiences and exploring their options, you will be equipped to offer compassionate, professional and attentive care when your patients ask questions or come to dispense their medications